𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma

✍ Scribed by Alain C. Jung; Jenny Briolat; Régine Millon; Aurélien de Reyniès; David Rickman; Emilie Thomas; Joseph Abecassis; Christine Clavel; Bohdan Wasylyk


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
489 KB
Volume
126
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Human papillomaviruses (HPV) are associated with a subset of head and neck squamous cell carcinoma (HNSCC), particularly HPV16. This study analyzed the presence and genotype of high risk HPVs, viral DNA load and transcription of the E6/E7 mRNAs, in 231 consecutive HNSCC. Twelve out of 30 HPV16 DNA‐positive tumors displayed high E6/E7 mRNAs levels and were localized in the oropharyngeal region. While HPV‐free and non‐transcriptionally active HPV‐related patients showed similar 5‐years survival rates, E6/E7 expression was associated with a better prognosis. This emphasizes the importance of considering the transcriptional status of HPV‐positive tumors for patient stratification. A gene expression profiling analysis of these different types of tumors was carried out. The most significant differentially expressed gene was CDKN2A, a known biomarker for HPV‐related cancer. Assessing both the expression level of the E6/E7 mRNAs and of CDKN2A in HNSCC is required to detect active HPV infection. Chromosomic alterations were investigated by Comparative Genomic Hybridation (CGH) analysis of tumors with transcriptionally active HPV and HPV‐negative tumors. The loss of the chromosomal region 16q was found to be a major genetic event in HPV‐positive lesions. A cluster of genes located in 16q21‐24 displayed decreased expression levels, notably APP‐BP1 that is involved in the modulation of the transcriptional activity of p53. In conclusion, this study highlights important criteria required to predict clinically active HPV infection, identifies new biological pathways implicated in HPV tumorigenesis and increases the understanding of HPV‐HNSCC physiopathology that is required to develop new targets for therapy.


📜 SIMILAR VOLUMES


p53 codon 72 polymorphisms in human papi
✍ Federica Perrone; Luigi Mariani; Elisa Pastore; Marta Orsenigo; Simona Suardi; B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract ## BACKGROUND. Tobacco smoking, alcohol abuse, and high‐risk human papillomavirus (HPV) are risk factors in the etiology of oropharyngeal squamous cell carcinomas (SCCs). The __TP53__ polymorphism, in which an arginine (R) is changed to proline (P) at codon 72, is functionally signific

Human papillomavirus infection and cycli
✍ Giovanni Almadori; Jacopo Galli; Gabriella Cadoni; Francesco Bussu; Maurizio Mau 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

## Background: Human papillomavirus (hpv) infection is suspected to be a risk factor for head and neck, and in particular for laryngeal, carcinogenesis. cyclin d1 gene (ccnd1) overexpression and amplification have been shown to play a role as prognostic factors in many human cancers, among which ar

Human papillomavirus (HPV) in head and n
✍ I. Benjamin Paz; Nathan Cook; Tamara Odom-Maryon; Yuan Xie; Sharon P. Wilczynski 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

tissue examined. This study was undertaken to estimate the frequency of HPV DNA in squamous cell carcinoma (SCC) at different sites of the esophagus, head and neck and

Expression of cell cycle markers and hum
✍ Lorenzo Lo Muzio; Matteo D'Angelo; Maurizio Procaccini; Fabrizio Bambini; France 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 463 KB 👁 1 views

## Abstract Our aim was to evaluate in oral squamous cell carcinoma (OSCC) the relationship between some cell cycle markers and HPV infection, conditionally to age, gender and certain habits of patients, and to assess the ability of fuzzy neural networks (FNNs) in building up an adequate predictive